Target intelligence / Profile preview

Botulinum neurotoxin type E

Molecular classification: Enzyme, Metalloprotease, Toxin

Overview

Botulinum neurotoxin type E (BoNT/E) is a potent neurotoxic protein produced by Clostridium botulinum. It inhibits acetylcholine release at neuromuscular junctions by cleaving SNAP-25, a SNARE protein, leading to flaccid paralysis. While primarily known for causing botulism, engineered forms are being investigated for therapeutic applications.

Mechanism of action

Cleaves SNAP‑25, blocking acetylcholine release at neuromuscular junctions, leading to flaccid paralysis.

Biological functions

Neurotransmission inhibitionSNAP-25 cleavageAcetylcholine release inhibition

Disease associations

Botulism

Safety considerations

Potent neurotoxinCauses flaccid paralysisPotential for respiratory or cardiac failureRisk of botulism

Beyond the preview

Go deeper on Botulinum neurotoxin type E.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Botulinum neurotoxin type E.

Explore the full profile